BDSX FY 2025 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

FY 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$88M+24.1% YoY

Gross Profit

$67M75.2% margin

Operating Income

-$28M-31.5% margin

Net Income

-$35M-39.8% margin

EPS (Diluted)

$-4.67

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$24M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$87M

Total Liabilities

$90M

Stockholders' Equity

-$2M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$71M	+24.1%
Gross Profit	$67M	$56M	+19.5%
Operating Income	-$28M	-$34M	+19.2%
Net Income	-$35M	-$43M	+17.9%